Scott Sullinger
Corporate Officer/Principal presso Egon Zehnder International, Inc.
Posizioni attive di Scott Sullinger
Società | Posizione | Inizio | Fine |
---|---|---|---|
Egon Zehnder International, Inc.
Egon Zehnder International, Inc. Miscellaneous Commercial ServicesCommercial Services Egon Zehnder International, Inc. provides advisory services. The company is headquartered in New York, NY. | Corporate Officer/Principal | 22/12/2009 | - |
Storia della carriera di Scott Sullinger
Precedenti posizioni note di Scott Sullinger
Società | Posizione | Inizio | Fine |
---|---|---|---|
NEOMAGIC CORPORATION | Direttore/Membro del Consiglio | 31/08/2010 | 30/05/2012 |
Independent Dir/Board Member | 30/08/2010 | 30/05/2012 | |
MEDISTEM INC | Direttore/Membro del Consiglio | 01/01/2009 | 01/01/2009 |
NEOMAGIC CORPORATION | Direttore Finanziario/CFO | 01/03/2004 | 01/03/2007 |
Formazione di Scott Sullinger
University of California, Los Angeles | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Electronic Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEOMAGIC CORPORATION | Electronic Technology |
Aziende private | 2 |
---|---|
Egon Zehnder International, Inc.
Egon Zehnder International, Inc. Miscellaneous Commercial ServicesCommercial Services Egon Zehnder International, Inc. provides advisory services. The company is headquartered in New York, NY. | Commercial Services |
Medistem, Inc.
Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Scott Sullinger
- Esperienza